Your browser version may not work well with NCBI's Web applications. More information here...
1: Arq Bras Cardiol. 2005 Oct;85 Suppl 5:25-7. Epub 2006 Jan 2.Click here to read Links

[Mechanisms of hepatotoxicity]

[Article in Portuguese]

Instituto Dante Pazzanese de Cardiologia, Secretaria de Estado da Saúde de São Paulo.

Liver disease following the use of hypolipidemic drugs has been reported as a cellular damage (increases in AST or ALT enzymes) without cholestatic alterations (bilirubin and or alkaline phosphatase increases). Six mechanisms were proposed for hepatotoxicity: 1. High energy reactions on P450 cytochrome impairing calcium homeostasis with rupture of intracellular fibrils and hepatocyte lysis. 2. Impairment of transporter proteins related to the bile acids flux (mechanism proposed for fibrate liver toxicity). 3. Immune reactions due to the formation of metabolites linked to enzymes following liver metabolism of hypolipidemic drugs. 4. Hepatotoxicity by T cells with additional inflammation mediated by neutrophils. 5. Apoptosis mediated by TNF and Fas (immune mediated). 6. Oxidative stress due to damage of intracellular organelles. In addition, advanced age, alcohol in excess, high doses of hypolipidemic drugs, interaction with other drugs, and previous active liver disease might increase liver toxicity.

PMID: 16400394 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Niacin (Advicor® , Niacor® , Niaspan® )

    Niacin is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in your blood. Niacin is also used to prevent and treat pellagra (niacin defic...

  • Glipizide (Metaglip, Glucovance, Avandamet, ...)

    In patients with diabetes or hyperlipidemia, how do combination drugs compare in improving long-term health?

Recent Activity